Effects of 1, 5-anhydro-D-fructose ingestion on arterial function

Effects of 1, 5-anhydro-D-fructose ingestion on arterial function - Effects of 1, 5-anhydro-D-fructose ingestion

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000042815

Enrollment

Registered

2020-12-23

Start date

2020-12-23

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy young adults

Interventions

Control-pure water (100 mL) and dextrin (1640 mg) ingestion Single ingestion, Cross-over design of two conditions Intervention-pure water (100 mL) and 1, 5-anhydro-D-fructose (1640 mg) ingestion Si

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 18 years and older men and women, not restricted by a doctor from exercising, not have medication and smoking.

Exclusion criteria

Exclusion criteria: Have a cardiovascular and cerebrovascular diseases.

Design outcomes

Primary

Measure	Time frame
Arterial stiffness (after 60-, 120-, and 180-min) Flow-mediated dilation (after 60-, 120-, and 180-min)	—

Countries

Japan

Contacts

Public ContactMasato Nishiwaki

Osaka Institute of Technology Faculty of Engineering

masato.nishiwaki@oit.ac.jp06-6954-4391

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026